WisdomTree offers three funds—DGRW, DLN, and DGRS—that distribute dividends monthly, unlike most quarterly payers. DGRW focuses on quality growth large caps, including tech firms with modest but growing dividends, delivering steady monthly payouts and strong long-term returns. DLN targets large-cap dividend payers weighted by dividend size, offering a classic dividend portfolio with stable income but slower growth. DGRS invests in small-cap dividend growth stocks, providing higher risk and return with monthly income. These funds suit different investor needs for monthly income and growth exposure without relying on leverage or option premiums.
Piper Sandler raised AbbVie's price target to $303, indicating a potential 13.92% upside from its current price of $265.97. This reflects positive expectations for the biopharmaceutical company's future performance. Institutional investors like J. M....
BTIG reaffirmed its 'Buy' rating for Glaukos and increased the price target to $202, citing strong sales growth. U.S. glaucoma sales rose 64% to $118.5 million, driven by the iDose TR product, while Corneal Health revenues grew 48% to $30.4 million, ...
Berkshire Hathaway has allocated 29.7% of its $356 billion investment portfolio to just two artificial intelligence stocks. This significant concentration underscores the growing confidence and interest in AI technologies as key drivers of future gro...
Wolfe Research has increased its price target for Fox Corporation to $93, indicating a strong positive outlook for the media company. This new target suggests a potential 54% gain from the current stock price of around $60.39, well above its 52-week ...
Autodesk, a major design software company with a market cap of about $53 billion, has seen its stock rise 15.26% over the past month, outperforming its sector and the S&P 500. Despite a recent "Neutral" rating from Citigroup and some daily price fluc...
